Luděk Raida researcher
Raida, Luděk, 1968-
VIAF ID: 85513155 (Personal)
Permalink: http://viaf.org/viaf/85513155
Preferred Forms
- 100 0 _ ‡a Luděk Raida ‡c researcher
- 100 1 _ ‡a Raida, Luděk ‡d 1968-
-
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experienc | |
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study. | |
ATM gene single nucleotide polymorphisms predict regimen-related gastrointestinal toxicity in patients allografted after reduced conditioning | |
[Bacterial strains isolated from neutropenic patients and their resistance to antibiotics] | |
Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma? | |
Cerebral salt wasting syndrome in a patient with primary CNS lymphoma. | |
[Chemotherapy of BOVAPEC in the primary treatment of Hodgkin's lymphoma intermediate stages] | |
Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma. | |
Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia | |
Comparison of reduced conditionings combining fludarabine with melphalan or 3-day busulfan in patients allografted for myeloid neoplasms | |
Glycoconjugates in colon mucosa during the development of human fetuses | |
High incidence of unbalanced chromosomal changes in mantle cell lymphoma detected by comparative genomic hybridization. | |
High serum carbohydrate antigen-125 (CA-125) level predicts poor outcome in patients with follicular lymphoma independently of the FLIPI score | |
Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML with marked basophilia: implications for treatment strategy. | |
[The incidence of nonfermentative gram-negative bacilli in the environment of the transplant unit, department of hemato-oncology, university hospital Olomouc] | |
[Interferon-alpha in the treatment of patients with chronic myeloid leukemia] | |
Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation. | |
[Methods in molecular cytogenetics for determination of prognostically important chromosome changes in patients with chronic lymphatic leukemias] | |
Monitoring of Microscopic Filamentous Fungi in Indoor Air of Transplant Unit | |
[Morphologic changes in lung tissue in mice after long-term exposure to NO2] | |
A novel HLA-B allele, HLA-B*35:279, identified by sequencing-based typing in a Czech patient. | |
The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic use. | |
Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up | |
Possible impact of MADCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic hematopoietic stem cell transplantation | |
Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia. | |
[Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000] | |
The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study. | |
Relapsed follicular lymphoma sequentially treated with rituximab and 90Y-ibritumomab tiuxetan. Case report. | |
Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission | |
[Selective depletion of alloreactive T cells and study of anti-tumor activity of specific T cell clones in patients with leukemia] | |
A single amino acid exchange shifts the serological reactivity of the novel HLA-B*4442 allele product from HLA-B44 to HLA-B21. | |
Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era. | |
Somatic mutation in acute myelogenous leukemia cells imitate novel germline HLA-A allele: a case report. | |
Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma. | |
Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma. | |
Therapeutic effectiveness of cladribine and cellular immunodeficiency--related effects in hairy-cell leukemia? | |
[Toxoplasmosis after immunosuppressive therapy--our experience] | |
[Treatment of patients with relapsed/refractory Hodgkin lymphoma] |